Skin-Derived Dendritic Cells Induce Potent CD8+ T Cell Immunity in Recombinant Lentivector-Mediated Genetic Immunization
Open Access
- 31 May 2006
- journal article
- research article
- Published by Elsevier BV in Immunity
- Vol. 24 (5), 643-656
- https://doi.org/10.1016/j.immuni.2006.03.014
Abstract
No abstract availableThis publication has 65 references indexed in Scilit:
- UNDERSTANDING PRESENTATION OF VIRAL ANTIGENS TO CD8+T CELLS IN VIVO: The Key to Rational Vaccine DesignAnnual Review of Immunology, 2005
- Langerhans Cells Activate Naive Self-Antigen-Specific CD8 T Cells in the Steady StateImmunity, 2004
- DC-virus interplay: a double edged swordSeminars in Immunology, 2004
- T-cell priming by dendritic cells in lymph nodes occurs in three distinct phasesNature, 2004
- Giving Credit Where Credit Is DueScience, 2003
- DNA vaccinationEmerging Drugs, 2003
- CD8α2 CD11b+ Dendritic Cells Present Exogenous Virus-like Particles to CD8+ T Cells and Subsequently Express CD8α and CD205 MoleculesThe Journal of Experimental Medicine, 2002
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivoNature Immunology, 2002
- Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.The Journal of Experimental Medicine, 1996